<p><strong>CSL</strong> is interested in research developing novel therapeutic candidates or exploring novel drug targets for cardiovascular disease, with a particular <strong>focus on rare cardiovascular diseases</strong>. CSL has a high interest in engaging with academic research focusing on <strong>biologics as well as cell and gene therapies</strong> (including gene editing), with a particular interest in <strong>plasma-derived protein therapeutics</strong>.</p> <h3><strong>Areas of Particular Interest</strong></h3> <ul> <li>Rare Lipid Disorders</li> <li>Myocarditis</li> <li>Animal Models of Myocarditis</li> <li>Familial Cardiomyopathies</li> <li>Refractory Angina</li> </ul> <h3><strong>Development Stage</strong></h3> <ul> <li>Opportunities...</li></ul>

CSL is interested in research developing novel therapeutic candidates or exploring novel drug targets for cardiovascular disease, with a particular focus on rare cardiovascular diseases.

Seeking Novel Drug Candidates and Targets for Cardiovascular Disorders

Areas of Particular Interest

Development Stage

Opportunity types being sought:

To see the full details and submit your response please register now.

Benefits of registration:

Opportunity types being sought: